Can-Fite Biopharma


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Can-Fite is an Israeli science-based biopharmaceutical company with the mission to develop treatments for autoimmune diseases and cancer. The company's drugs which piggyback on a natural mechanism, are small molecules, orally administered, induce specific activity towards their target pathological cells and demonstrated an excellent safety profile in human clinical studies.

Can-Fite is an Israeli science-based biopharmaceutical company with the mission to develop treatments for autoimmune diseases and cancer. The company's drugs which piggyback on a natural mechanism, are small molecules, orally administered, induce spe...Show all

Company (Alive / Active)

Phone:

Fax:

10 Bareket Street , Kiryat Matalon
P.O. Box 7537
49170
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Can-Fite Biopharma $0M Mar 7, 2019
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Can-Fite Biopharma Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
A3 adenosine receptor ligands for use in treatment of a sexual dysfunction Aug 08, 2013 Jan 24, 2017 Patent
Method for inducing hepatocyte proliferation and uses thereof Aug 21, 2014 Jul 12, 2016 Patent
Process for the synthesis of ib-meca Mar 13, 2008 Aug 11, 2015 Patent
Pharmaceutical composition including an a3 adenosine receptor agonist 1-deooxy-1-[n Sep 06, 2010 Mar 24, 2015 Patent
Method for inducing hepatocyte proliferation and uses thereof Oct 22, 2008 Sep 30, 2014 Patent
See all 12 patents